Showing results (81-90 of 133) with videos related to
Sort By:
Pageof 14
British Medical Journal (Clinical Research Ed.)|August 18, 1984
Beta blockade, diuretics, and salt restriction for the management of mild hypertension: a randomised double blind trialT M Erwteman, N Nagelkerke, J Lubsen, et al.Statistics in Medicine|December 1, 1987
Early termination of clinical trials with prolonged observation of individual patients: a case studyG A van Es, J G Tijssen, J Lubsen, et al.Circulation|July 1, 1993
Heart rate variability from 24-hour electrocardiography and the 2-year risk for sudden deathA Algra, J G Tijssen, J R Roelandt, et al.Journal of the American College of Cardiology|October 5, 2001
The effect of risk factor reductions between 1981 and 1990 on coronary heart disease incidence, prevalence, mortality and costL Goldman, K A Phillips, P Coxson, et al.JAMA|July 12, 1995
Revascularization for femoropopliteal disease. A decision and cost-effectiveness analysisM G Hunink, J B Wong, M C Donaldson, et al.European Journal of Epidemiology|May 1, 1993
Cardiovascular risk and all-cause mortality; a 12 year follow-up study in The NetherlandsA W Hoes, D E Grobbee, H A Valkenburg, et al.The American Journal of Cardiology|July 15, 1993
Left ventricular systolic and diastolic function, and exercise capacity six to eight weeks after acute myocardial infarction. The DEFIANT Study Group. Doppler Flow and Echocardiography in Functional Cardiac Insufficiency: Assessment of Nisoldipine TherapyB S Lewis, S N Emmott, J Smyllie, et al.Statistics in Medicine|December 21, 2000
Baseline risk as predictor of treatment benefit: three clinical meta-re-analysesL R Arends, A W Hoes, J Lubsen, et al.European Heart Journal|July 1, 1988
Serum potassium values in relation to the use of diuretics in patients with unstable angina pectorisW H van Gilst, J G Tijssen, G A van Es, et al.Journal of the American College of Cardiology|September 14, 1999
The relative influence of secondary versus primary prevention using the National Cholesterol Education Program Adult Treatment Panel II guidelinesL Goldman, P Coxson, M G Hunink, et al.Pageof 14